Lilly May Face Q2 Blues As Prior Stocking Takes Effect

 
• By Joseph Haas
  
Positive, young woman looking through a spyglass in front of a blackboard as a crossroad arrows splitted in three different ways. Choosing between up, down and ahead. Difficult decision concept.
Lilly investors will be eager to hear how the firm's diabetes and cancer franchises held up during Q2
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business